Remission of rosacea induced by reduction of gut transit time

Clinical and Experimental Dermatology

Volumn 29, Issue 3, 2004, Pages 297-299

  Kendall, S N ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; KALLIKREIN; KININ;

ADULT; ANAMNESIS; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FLUID THERAPY; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; HUMAN; INTESTINE FLORA; INTESTINE TRANSIT TIME; KALLIKREIN KININ SYSTEM; MALE; NEUROGENIC INFLAMMATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; ROSACEA; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; CONSTIPATION; DIETARY FIBER; GASTROINTESTINAL TRANSIT; HUMANS; MALE; REMISSION INDUCTION; ROSACEA;

EID: 2442669160     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01461.x     Document Type: Article

References (16)

1. Walton S, Sheth M, Wyatt EH. Rosacea and ulcerative colitis: a possible association. J Clin Gastroenterol 1990; 12: 513-5.
2. Romiti R, Jansen T, Heldwein W, Plewig G. Rosacea fulminans in a patient with Crohn's disease: a case report and review of the literature. Acta Derm Venereol 2000; 80: 127-9.
3. Usher B, Young G. Gastroscopic studies in rosacea. Can Med Assoc J 1956; 75: 111-3.
4. Watson WC, Paton E, Murray D. Small bowel disease in rosacea. Lancet 1965; 7401: 47.
5. Brown WH, Smith MS, McLachlan AD. Fractional gastric analysis in diseases of the skin: Further observation in 316 cases with special reference to rosacea. Br J Derm Syph 1935; 47: 181-90.
6. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology 1995; 191: 6-8.
7. Sharma JN, Zeitlin IJ, Mackenzie JF, Russell RI. Plasma kinin-precursor levels in clinical intestinal inflammation. Fundam Clin Pharmacol 1988; 2: 399-403.
8. Snitsarenko OV. Vasoactive polypeptides in rosacea. Vestn Dermatol Venerol 1989; 9: 42-4.
9. Guarrera M, Parodi A, Cipriani C et al. Flushing in rosacea: a possible mechanism. Arch Dermatol Res 1982; 272: 311-6.
10. Prantera C, Berto E, Scribano ML, Falasco G. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998; 30: 602-6.
11. Stadnicki A, DeLa Cadena RA, Sartor RB et al. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat. Dig Dis Sci 1996; 41: 912-20.
12. Kurkcuoglu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol 1991; 25: 725-6.
13. Tan SG, Cunliffe WJ. Rosacea and migraine. Br Med J 1976; 6000: 21.
14. Pimentel M, Chow EJ, Hallegua D et al. Small bowel bacterial overgrowth: a possible association with fibromyalgia. J Musculoskeletal Pain 2001; 9: 107-13.
15. Finegold SM, Molitoris D, Song Y et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002; 35: S6-S16.
16. Sandler RH, Finegold SM, Bolte ER et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000; 15: 429-35.